Filing Details

Accession Number:
0001209191-23-016046
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-03 19:57:33
Reporting Period:
2023-03-01
Accepted Time:
2023-03-03 19:57:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1515673 Ultragenyx Pharmaceutical Inc. RARE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1303811 Richard Thomas Kassberg C/O Ultragenyx Pharmaceutical Inc.
60 Leveroni Court
Novato CA 94949
Cbo & Evp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-01 2,663 $0.00 230,222 No 4 A Direct
Common Stock Acquisiton 2023-03-01 22,000 $0.00 252,222 No 4 A Direct
Common Stock Disposition 2023-03-01 1,968 $45.27 250,254 No 4 S Direct
Common Stock Disposition 2023-03-01 3,394 $45.65 246,860 No 4 D Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 A Direct
No 4 S Direct
No 4 D Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2023-03-01 39,400 $0.00 39,400 $45.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
39,400 2033-03-01 No 4 A Direct
Footnotes
  1. Represents shares of common stock which previously granted performance stock units were converted on March 1, 2023 upon certification of the performance metric.
  2. Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.
  3. Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
  4. Shares were acquired upon the partial vesting of a previously reported RSU and were sold to permit the cash value of the awards to be credited to the deferred compensation plan account of the Reporting Person
  5. Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
  6. On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.